Advertisement

Serological Inhibition of Graft Versus Host Disease: Recent Results in 28 Patients with Leukemia

  • H. Rodt
  • S. Thierfelder
  • C. Bender-Götze
  • R. Dopfer
  • F. J. Haas
  • G. Janka
  • H. J. Kolb
  • H. Link
  • B. Netzel
  • D. Niethammer
  • K. Schüch
  • K. Wilms
Conference paper
Part of the Haematology and Blood Transfusion / Hämatologie und Bluttransfusion book series (HAEMATOLOGY, volume 28)

Abstract

One major obstacle to the successful application of allogeneic bone marrow transplantation is the occurrence of immunologic complications when donor and recipient are not monozygous twins and express differences in their histocompatibility properties. Even after transplantation of HLA-identical and MLC-negative marrow grafts the occurrence of graft versus host disease (GvHD) cannot be excluded due to genetic differences not detected by present histocompatibility typing techniques. In the past, several experimental approaches have been designed to eliminate the GvH-reactive cell populations in the donor marrow by incubating the graft in vitro with specific antibody preparations whose stem cell toxicity had been absorbed by various tissues, in particular non-T-lymphocytes. Pretreatment of donor spleen marrow with absorbed anti-T cell antisera suppressed GvHD in over 90% of H-2 incompatible semiallogeneic mice preirradiated with 900 R [1]. Also monoclonal Anti-Th-1 antibodies have been effective in preventing GvH reactions in incompatible murine combinations [2]. A suppressing effect of GvHD by incubation with T-cell-specific antibodies could also be shown in a canine model transferring incompatible DLA homozygous marrow to DLA heterozygous lethally irradiated littermates [3]. Since then an anti-T-cell globulin for human cells with comparable serological characteristics has been developed [4]. The present report describes the effect of an incubation treatment with anti-T-cell globulin in 28 cases of bone marrow transplantation in acute leukemias.

Keywords

Acute Myeloid Leukemia Bone Marrow Transplantation Chronic Myeloid Leukemia Total Body Irradiation Graft Versus Host Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Rodt H, Thierfelder S, Eulitz M (1974) Antilymphocytic antibodies and marrow transplantation. III. Effect of heterologous antibrain antibodies on acute secondary disease in mice. Eur J Immunol 4:25CrossRefGoogle Scholar
  2. 2.
    Thierfelder S, Hoffmann-Fezer G, Rodt H, Doxiadis I, Eulitz M, Kummer U (to be published) Antilymphocytic antibodies and marrow transplantation. VI. No immunosuppression in vivo after infection of monoclonal antibodies which blocked GvHR and humoral antibody formation in vitro. TransplantationGoogle Scholar
  3. 3.
    Kolb HJ, Bodenberger U, Rodt H, Rieder I, Netzel B, Grosse-Wilde H, Scholz S, Thierfelder S (1980) Bone marrow transplantation in DLA-haploidentical canine littermates. Fractionated total body irradiation (FTBI) and in vitro treatment of the marrow graft with anti-T-cell globulin (ATCG). In: Thierfelder S, Rodt H, Kolb HJ (eds) Immunobiology of bone marrow transplantation. Springer, Berlin Heidelberg New York p 61CrossRefGoogle Scholar
  4. 4.
    Rodt H, Thierfelder S, Thiel E, Götze D, Netzel B, Huhn D, Eulitz M (1975) Identification and quantitation of human T-cell antigen by antisera purified from antibodies crossreacting with hemopoietic progenitors and other blood cells. Immunogenetics 2:411CrossRefGoogle Scholar
  5. 5.
    Rodt H, Thierfelder S, Netzel B, Kolb HJ, Thiel E, Niethammer D, Haas RJ (1977) Specific absorbed anti-thymocyte globulin for incubation treatment in human marrow transplantation. Transplant Proc 9: 187PubMedGoogle Scholar
  6. 6.
    Rodt H, Netzel B, Kolb HJ, Janka G, Rieder I, Beloradsky B, Haas RJ, Thierfelder S (1979) Antibody treatment of marrow grafts in vitro: A principle for prevention of graftversus-host disease. In: Baum S, Ledney GD (eds) Experimental hematology today. Springer, Berlin Heidelberg New York, p 197Google Scholar
  7. 7.
    Kolb HJ, Rieder I, Grosse-Wilde H, Bodenberger U, Scholz S, Kolb H, Schäffer E, Thierfelder S (1979) Graft-versus-host disease (GvHD) following marrow graft from DLA matched canine littermates. Transplant Proc 11:507PubMedGoogle Scholar
  8. 8.
    Storb R, Weiden PL, Prentice R, Buchner CD, Clift RA, Einstein AB, Fefer A, Johnson FL, Lerner KG, Neiman PE, Sanders JE, Thomas ED (1977) Aplastic anemia (AA) treated by allogeneic marrow transplantation: The Seattle Experience. Transplant Proc 9: 181PubMedGoogle Scholar
  9. 9.
    Rodt H, Thierfelder S, Kummer U (1982) Suppression of GvHD by monoclonal antisera. Exp Hematol 10, Suppl 10: 107Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1983

Authors and Affiliations

  • H. Rodt
  • S. Thierfelder
  • C. Bender-Götze
  • R. Dopfer
  • F. J. Haas
  • G. Janka
  • H. J. Kolb
  • H. Link
  • B. Netzel
  • D. Niethammer
  • K. Schüch
  • K. Wilms

There are no affiliations available

Personalised recommendations